<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(6)</volume><submitter>Wang CJ</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Reperfusion therapy is the most effective treatment for acute ischemic stroke but remains underused in China.&lt;h4>Objective&lt;/h4>To evaluate the effect of a problem-oriented, culturally adapted, targeted quality improvement intervention on reperfusion therapy for patients with acute ischemic stroke in China.&lt;h4>Design, setting, and participants&lt;/h4>In this stepped-wedge cluster randomized clinical trial, patients from 16 secondary and 33 tertiary hospitals in China with acute ischemic stroke within 6 hours of symptom onset were consecutively recruited between July 1, 2018, and June 30, 2020.&lt;h4>Interventions&lt;/h4>Hospitals were randomly assigned to 1 of 3 sequences to receive the targeted quality improvement intervention (n = 5689), in which workflow reconstruction was prom</pubmed_abstract><journal>JAMA network open</journal><pagination>e2316465</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10238948</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effectiveness of a Quality Improvement Intervention on Reperfusion Treatment for Patients With Acute Ischemic Stroke: A Stepped-Wedge Cluster Randomized Clinical Trial.</pubmed_title><pmcid>PMC10238948</pmcid><pubmed_authors>Liu LP</pubmed_authors><pubmed_authors>Huang D</pubmed_authors><pubmed_authors>Liu XY</pubmed_authors><pubmed_authors>Schwamm LH</pubmed_authors><pubmed_authors>Guo Z</pubmed_authors><pubmed_authors>Wang CJ</pubmed_authors><pubmed_authors>Zong LX</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Hao Y</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Wang N</pubmed_authors><pubmed_authors>Sun P</pubmed_authors><pubmed_authors>Guo J</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Dong J</pubmed_authors><pubmed_authors>Gu J</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Hu SQ</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Yang G</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Jin X</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Xie Z</pubmed_authors><pubmed_authors>Xian Y</pubmed_authors><pubmed_authors>IMPROVE Stroke Care in China investigators</pubmed_authors><pubmed_authors>Chen G</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Wang YJ</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Wang YL</pubmed_authors><pubmed_authors>Ma XD</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Wangqin RQ</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Zhang XM</pubmed_authors><pubmed_authors>Ma Q</pubmed_authors><pubmed_authors>Cao M</pubmed_authors><pubmed_authors>Bei YZ</pubmed_authors><pubmed_authors>Gu HQ</pubmed_authors><pubmed_authors>Ren Y</pubmed_authors><pubmed_authors>Liu P</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Meng X</pubmed_authors><pubmed_authors>Niu X</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Wang ZM</pubmed_authors><pubmed_authors>Tang M</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Zhou C</pubmed_authors><pubmed_authors>Li A</pubmed_authors><pubmed_authors>Zhou Q</pubmed_authors><pubmed_authors>Huo XC</pubmed_authors><pubmed_authors>Zhao XQ</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Qi XH</pubmed_authors><pubmed_authors>Li ZX</pubmed_authors><pubmed_authors>Kong X</pubmed_authors><pubmed_authors>Morgan L</pubmed_authors><pubmed_authors>Ma G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effectiveness of a Quality Improvement Intervention on Reperfusion Treatment for Patients With Acute Ischemic Stroke: A Stepped-Wedge Cluster Randomized Clinical Trial.</name><description>&lt;h4>Importance&lt;/h4>Reperfusion therapy is the most effective treatment for acute ischemic stroke but remains underused in China.&lt;h4>Objective&lt;/h4>To evaluate the effect of a problem-oriented, culturally adapted, targeted quality improvement intervention on reperfusion therapy for patients with acute ischemic stroke in China.&lt;h4>Design, setting, and participants&lt;/h4>In this stepped-wedge cluster randomized clinical trial, patients from 16 secondary and 33 tertiary hospitals in China with acute ischemic stroke within 6 hours of symptom onset were consecutively recruited between July 1, 2018, and June 30, 2020.&lt;h4>Interventions&lt;/h4>Hospitals were randomly assigned to 1 of 3 sequences to receive the targeted quality improvement intervention (n = 5689), in which workflow reconstruction was prom</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2026-05-29T03:24:55.337Z</modification><creation>2025-04-06T11:13:29.478Z</creation></dates><accession>S-EPMC10238948</accession><cross_references><pubmed>37266940</pubmed><doi>10.1001/jamanetworkopen.2023.16465</doi></cross_references></HashMap>